Filters

ALPK1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

ALPK1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) size: 1.0 µg DNA 322

Supplier ABM LENTIVECTORS
Price 322
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetALPK1 Lentiviral Vector (CMV) (pLenti-GIII-CMV-C-term-HA)
Short nameALPK1 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-C-term-HA)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-c terminus-HA), ALPK1 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 20917
Gene ALPK1
Long gene name alpha kinase 1
Synonyms Lak FLJ22670 KIAA1527
Synonyms name lymphocyte alpha-kinase
Locus 4q25
Discovery year 2004-12-01
GenBank acession AY044164
Entrez gene record 80216
Pubmed identfication 10021370 10819331
RefSeq identity NM_025144
Havana BLAST/BLAT OTTHUMG00000132911

Similar products

Subscribe to our Newsletter